Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 30%
Sell 10%
Strong Sell 0%

Bulls say

Alcon is well-positioned in the vision care industry due to its diverse product offerings in both the visioncare and surgical segments. The company has a strong market share in the contact lens and cataract surgery markets, with successful product launches for both segments. Management also has a strategic focus on expanding the company's presence in emerging markets, which could drive future growth. In addition, the company's recent spin-off from Novartis allows it to focus solely on its vision care business, providing potential for better operational efficiency and growth opportunities.

Bears say

Alcon is currently experiencing stable growth in its contact lens and surgical segments, driven by new product contributions. However, market growth is expected to remain subdued at 3-4%, with potential risks of market share losses and slower margin improvement. Additionally, concerns over tougher comps in the second half of FY26 and increased operating spending may weigh on profitability. The success of ALC's top-line growth and cost management strategies will be key factors in determining its future performance.

ALC has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 10 analysts, ALC has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.